Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
67%
ALSO IN WDNA
WDNA
85
HOLDINGS
19%
ALSO IN BBH
SECTOR DRIFT (BBH minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.2% | 4.4% | 4.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.7% | 3.0% | 3.0% |
|
UNITED THERAPEUTICS CORP | 3.7% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 11.6% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 9.5% | 1.5% | 1.5% |
BBH Overweight Relative to WDNA
|
AMGEN INC | 11.1% |
|
GILEAD SCIENCES INC | 9.7% |
|
VERTEX PHARMACEUTICALS INC | 8.0% |
|
INSMED INC | 5.3% |
|
REGENERON PHARMACEUTICALS | 4.8% |
|
IQVIA HOLDINGS INC | 4.7% |
 |
ARGENX SE ADR | 3.8% |
|
BEIGENE LTD. SPONSORED ADR | 3.8% |
 |
ICON PLC | 3.1% |
|
BIOGEN IDEC INC | 2.9% |
BBH Underweight Relative to WDNA
|
BRIDGEBIO PHARMA, INC. | -4.0% |
|
BLUEPRINT MEDICINES CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
STOKE THERAPEUTICS, INC. | -2.3% |
|
ELI LILLY & CO | -2.3% |
|
TWIST BIOSCIENCE CORP. | -2.2% |
|
AGIOS PHARMACEUTICALS INC | -2.1% |
|
IONIS PHARMACEUTICALS, INC. | -2.1% |
|
VERACYTE INC | -2.1% |
 |
NOVARTIS AG | -1.9% |